NEW YORK (GenomeWeb) – Cancer Genetics today announced it has received conditional licensure from the New York State Department of Health for its FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer.

The test, which received US approval as a laboratory-developed test under CLIA in late 2013, assesses genomic changes often found in cervical cancers and can identify women who are at higher risk for disease progression, the firm said in a statement. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.